Ultrasound-guided Lauromacrogol injection sclerotherapy in spermatic cord hydrocele

Huiwen Li,Jinrui Wang,Jianhua Wang,Xia Xu,Xue-rui Wang
DOI: https://doi.org/10.3877/cma.j.issn.1672-6448.2016.02.014
2016-01-01
Abstract:Objective To observe the treatment effect of ultrasound-guided sclerotherapy with Lauromacrogol injection.in spermatic cord hydrocele. Methods From May 2012 to December 2014, 35 children diagnosed as spermatic cord hydrocele in Ordos Central Hospital were included in the study. In treatment, ultrasound-guided puncture and drainage of the cyst was conducted, and then lauromacrogol was injected into the residual cystic cavity and retained for five minutes. In follow-up, curative effect was evaluated 1 month, 3 months, and 6 months after operation. Children could be treated again after the ineffective initial treatment. If the second treatment still failed, the children would be referred to surgery. Cured children needed to follow-up to observe the changes of spermatic cord. Results Totally 31 cases (88.6%) were cured by initial treatment, and 3 cases (8.6%) were cured at the second time. Only 1 case was referred to surgery after two unsuccessful treatments. The total curative rate was 97.1% (34/35). No children had discomfort during therapy. In follow-up, no inguinal region mass was found. Compared with the contralateral spermatic cord, the diameter of spermatic cord had no abnormal changes. Conclusion Ultrasound-guided Lauromacrogol injection sclerotherapy is a cost-effective method for spermatic cord hydrocele, which could avoid surgery for most children. Key words: Ultrasonography, interventional; Lauromacrogol; Sclerotherapy; Genital diseases, male
What problem does this paper attempt to address?